- Home
- SBFM vs AYRO Comparison
SBFM vs AYRO Comparison
Compare SBFM & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- AYRO
- Stock Information
- Founded
- SBFM 2006
- AYRO 2017
- Country
- SBFM United States
- AYRO United States
- Employees
- SBFM N/A
- AYRO N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- AYRO Telecommunications Equipment
- Sector
- SBFM Health Care
- AYRO Consumer Discretionary
- Exchange
- SBFM Nasdaq
- AYRO Nasdaq
- Market Cap
- SBFM 4.9M
- AYRO 4.1M
- IPO Year
- SBFM N/A
- AYRO N/A
- Fundamental
- Price
- SBFM $1.55
- AYRO $0.52
- Analyst Decision
- SBFM Strong Buy
- AYRO
- Analyst Count
- SBFM 1
- AYRO 0
- Target Price
- SBFM $15.00
- AYRO N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- AYRO 144.1K
- Earning Date
- SBFM 05-19-2025
- AYRO 05-14-2025
- Dividend Yield
- SBFM N/A
- AYRO N/A
- EPS Growth
- SBFM N/A
- AYRO N/A
- EPS
- SBFM N/A
- AYRO N/A
- Revenue
- SBFM $34,874,283.00
- AYRO $63,777.00
- Revenue This Year
- SBFM $192.48
- AYRO N/A
- Revenue Next Year
- SBFM N/A
- AYRO N/A
- P/E Ratio
- SBFM N/A
- AYRO N/A
- Revenue Growth
- SBFM 44.75
- AYRO N/A
- 52 Week Low
- SBFM $1.17
- AYRO $0.38
- 52 Week High
- SBFM $33.60
- AYRO $1.48
- Technical
- Relative Strength Index (RSI)
- SBFM 44.81
- AYRO 50.87
- Support Level
- SBFM $1.17
- AYRO $0.48
- Resistance Level
- SBFM $1.59
- AYRO $0.57
- Average True Range (ATR)
- SBFM 0.19
- AYRO 0.06
- MACD
- SBFM 0.03
- AYRO 0.01
- Stochastic Oscillator
- SBFM 52.84
- AYRO 72.63
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.